Akebia Therapeutics
Edit

Akebia Therapeutics

http://akebia.com/
Tags:DevelopmentHealthProduct
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Total raised: $72.1M

Investors 1

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
04.06.2013Series C$41M-vcnewsdail...
09.01.2012Series B$4.1M-vcnewsdail...
27.04.2011Series B$22M-finsmes.co...
16.06.2010Series A$5M-finsmes.co...

Mentions in press and media 54

DateTitleDescriptionCategoryAuthorSource
24.11.2021Akebia The...CAMBRIDGE, Mass., Nov. 24, 202...--marketscre...
15.11.2021Akebia The...CAMBRIDGE, Mass., Nov. 15, 202...--marketscre...
05.11.2021Akebia The...CAMBRIDGE, Mass. - Akebia Ther...--marketscre...
04.11.2021Akebia The...Akebia Therapeutics Reports Th...--marketscre...
29.10.2021Akebia Ann...CAMBRIDGE, Mass., Oct. 29, 202...--marketscre...
01.09.2021Akebia The...CAMBRIDGE, Mass., Sept. 1, 202...--marketscre...
01.09.2021Akebia The... CAMBRIDGE, Mass., Sept. 1, 2...--prnewswire...
03.06.2021Akebia The... CAMBRIDGE, Mass., June 3, 20...--prnewswire...
03.06.2021AKEBIA THE...CAMBRIDGE, Mass., June 3, 2021...--marketscre...
25.03.2021AKEBIA THE...CAMBRIDGE, Mass., March 25, 20...--marketscre...
Show more